Characterisation of resistance mechanisms developed by basal cell carcinoma cells in response to repeated cycles of Photodynamic Therapy.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
18 03 2019
Historique:
received: 06 08 2018
accepted: 04 03 2019
entrez: 20 3 2019
pubmed: 20 3 2019
medline: 29 10 2020
Statut: epublish

Résumé

Photodynamic Therapy (PDT) with methyl-aminolevulinate acid (MAL-PDT) is being used for the treatment of Basal cell carcinoma (BCC), but recurrences have been reported. In this work, we have evaluated resistance mechanisms to MAL-PDT developed by three BCC cell lines (ASZ, BSZ and CSZ), derived from mice on a ptch+/- background and with or without p53 expression, subjected to 10 cycles of PDT (10

Identifiants

pubmed: 30886381
doi: 10.1038/s41598-019-41313-y
pii: 10.1038/s41598-019-41313-y
pmc: PMC6423284
doi:

Substances chimiques

Patched-1 Receptor 0
Photosensitizing Agents 0
Protoporphyrins 0
Ptch1 protein, mouse 0
Trp53 protein, mouse 0
Tumor Suppressor Protein p53 0
methyl 5-aminolevulinate 585NM85KYM
Aminolevulinic Acid 88755TAZ87
protoporphyrin IX C2K325S808

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4835

Références

J Natl Cancer Inst. 1998 Jun 17;90(12):889-905
pubmed: 9637138
J Biosci. 2016 Sep;41(3):497-506
pubmed: 27581940
Int J Oncol. 2006 Aug;29(2):397-405
pubmed: 16820882
Br J Cancer. 1998 Jun;77(11):1744-51
pubmed: 9667642
Cancer Res. 1991 Aug 15;51(16):4243-9
pubmed: 1831066
J Natl Cancer Inst. 1987 Dec;79(6):1327-32
pubmed: 3480384
Cancer Lett. 2008 Oct 18;270(1):56-65
pubmed: 18513853
Pak J Pharm Sci. 2016 May;29(3):999-1003
pubmed: 27166545
Int J Mol Sci. 2017 Jul 31;18(8):
pubmed: 28788102
Mol Cell Biol. 2001 Oct;21(20):6768-81
pubmed: 11564862
Oncogene. 2002 Nov 14;21(52):7971-80
pubmed: 12439747
J Invest Dermatol. 2014 Sep;134(9):2428-2437
pubmed: 24717244
Actas Dermosifiliogr. 2016 Nov;107(9):740-750
pubmed: 27436804
Arch Dermatol Res. 2013 Nov;305(9):835-40
pubmed: 23589095
Nat Rev Mol Cell Biol. 2015 Jul;16(7):393-405
pubmed: 26122615
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Cell Mol Life Sci. 2000 Nov;57(12):1720-31
pubmed: 11130178
Exp Dermatol. 2006 Sep;15(9):742-50
pubmed: 16881970
JAAD Case Rep. 2018 Apr 30;4(5):408-411
pubmed: 29984265
J Biol Chem. 2007 Jun 8;282(23):16989-7001
pubmed: 17438332
Immunol Cell Biol. 2000 Aug;78(4):452-64
pubmed: 10947873
Cancers (Basel). 2017 Feb 18;9(2):
pubmed: 28218708
Br J Cancer. 1994 Jan;69(1):157-62
pubmed: 8286199
J Cutan Pathol. 2015 Nov;42(11):903-10
pubmed: 26268472
Nat Rev Clin Oncol. 2017 Oct;14(10):611-629
pubmed: 28397828
Int J Mol Med. 2014 Jan;33(1):151-9
pubmed: 24173500
Cancer Lett. 2008 Nov 28;271(2):342-51
pubmed: 18662847
Actas Dermosifiliogr. 2016 Nov;107(9):730-739
pubmed: 27436800
Sci Rep. 2017 Mar 15;7:44497
pubmed: 28295025
Front Oncol. 2014 Mar 06;4:40
pubmed: 24639951
FEBS J. 2014 Nov;281(21):4779-91
pubmed: 25158828
Br J Dermatol. 2004 Jul;151(1):157-64
pubmed: 15270885
Prostate. 2007 Dec 1;67(16):1751-60
pubmed: 17929268
J Dermatol Sci. 2011 Jan;61(1):7-13
pubmed: 21167690
Cancer Chemother Pharmacol. 2006 Aug;58(2):256-65
pubmed: 16283310
Pharmacol Ther. 2015 Jun;150:33-46
pubmed: 25595324
Lasers Surg Med. 2009 Apr;41(4):305-15
pubmed: 19347942
Acta Derm Venereol. 2018 Jan 12;98(1):116-118
pubmed: 28761963
J Cell Sci. 2013 Jan 15;126(Pt 2):393-401
pubmed: 23525005
Growth Factors. 2013 Feb;31(1):1-31
pubmed: 23256519
Mol Carcinog. 2017 Dec;56(12):2543-2557
pubmed: 28574612
Nature. 2018 Oct;562(7727):429-433
pubmed: 30297801
Actas Dermosifiliogr. 2010 Oct;101(8):683-92
pubmed: 20965011
J Natl Cancer Inst. 1973 Nov;51(5):1417-23
pubmed: 4357758
Biochem Pharmacol. 2017 Nov 15;144:63-77
pubmed: 28784290
Oncotarget. 2014 May 30;5(10):2881-911
pubmed: 24931005
Histopathology. 2010 May;56(6):799-809
pubmed: 20546345
Nat Rev Mol Cell Biol. 2014 Mar;15(3):178-96
pubmed: 24556840
J Cancer Res Clin Oncol. 2015 Oct;141(10):1697-713
pubmed: 25270087
Oncogene. 2004 May 27;23(25):4444-53
pubmed: 15064706
J Am Acad Dermatol. 2016 Mar;74(3):437-51; quiz 452-4
pubmed: 26892653
Recent Results Cancer Res. 2016;205:191-212
pubmed: 27075355
PLoS One. 2012;7(10):e47899
pubmed: 23110125
Am J Clin Dermatol. 2018 Apr;19(2):195-207
pubmed: 28887802
Cancer Lett. 2013 Aug 9;336(1):231-9
pubmed: 23673211
Expert Opin Pharmacother. 2017 May;18(7):689-699
pubmed: 28414587
Clin Cosmet Investig Dermatol. 2014 May 21;7:145-63
pubmed: 24899818
Cell Mol Life Sci. 2008 Nov;65(23):3756-88
pubmed: 18726070
Oncotarget. 2016 Jul 19;7(29):45876-45888
pubmed: 27322682
J Cell Biochem. 2011 Sep;112(9):2266-78
pubmed: 21503960
Prog Mol Biol Transl Sci. 2013;116:317-36
pubmed: 23481201
Photochem Photobiol. 1997 Jan;65(1):166-76
pubmed: 9066298
Cell Mol Life Sci. 2015 Nov;72(21):4077-94
pubmed: 26206378
Biochim Biophys Acta. 2013 Jan;1835(1):36-45
pubmed: 23046998
CA Cancer J Clin. 2011 Jul-Aug;61(4):250-81
pubmed: 21617154
Cancer Res. 1993 Oct 15;53(20):4994-9
pubmed: 8402690
PLoS One. 2013;8(2):e55289
pubmed: 23408967
Cancers (Basel). 2014 Sep 05;6(3):1769-92
pubmed: 25198391
Photochem Photobiol. 2001 Jun;73(6):651-6
pubmed: 11421071
Photochem Photobiol Sci. 2015 Aug;14(8):1378-89
pubmed: 25740707
Am J Med. 2016 Jul;129(7):655-60
pubmed: 27046242
J Immunother Cancer. 2018 Nov 20;6(1):126
pubmed: 30458852
Photochem Photobiol Sci. 2015 Oct;14(10):1765-80
pubmed: 26219737
J Photochem Photobiol B. 2006 Sep 1;84(3):213-20
pubmed: 16709459
Cancer Sci. 2016 Oct;107(10):1363-1372
pubmed: 27486911
Curr Med Chem. 2011;18(16):2486-515
pubmed: 21568910
Int J Cancer. 2013 Aug 15;133(4):807-15
pubmed: 23389968
Nat Med. 1999 Nov;5(11):1285-91
pubmed: 10545995
Nat Genet. 2016 Apr;48(4):398-406
pubmed: 26950094
Am J Clin Dermatol. 2014 Jul;15(3):197-216
pubmed: 24733429
J Pathol. 2010 Oct;222(2):129-37
pubmed: 20662002
Aging Cell. 2004 Oct;3(5):309-17
pubmed: 15379854
Cancer Cell. 2014 Mar 17;25(3):304-17
pubmed: 24651012

Auteurs

Silvia Rocio Lucena (SR)

Biology Department, Faculty of Sciences, Autonomous University of Madrid, Madrid, Spain.

Alicia Zamarrón (A)

Biology Department, Faculty of Sciences, Autonomous University of Madrid, Madrid, Spain.

Elisa Carrasco (E)

Molecular Biology Department, Faculty of Sciences, Autonomous University of Madrid, Madrid, Spain.

Miguel Angel Marigil (MA)

Pathology Service, Hospital San Jorge, Huesca, Spain.

Marta Mascaraque (M)

Biology Department, Faculty of Sciences, Autonomous University of Madrid, Madrid, Spain.

Montserrat Fernández-Guarino (M)

Dermatology Service, Hospital Ramón y Cajal, Madrid, Spain.

Yolanda Gilaberte (Y)

Dermatology Service, Hospital Miguel Servet, Zaragoza, Spain.

Salvador González (S)

Medicine and Medical Specialties Department, Alcalá de Henares University, Madrid, Spain.

Angeles Juarranz (A)

Biology Department, Faculty of Sciences, Autonomous University of Madrid, Madrid, Spain. angeles.juarranz@uam.es.
Instituto Ramón y Cajal de Investigaciones Sanitarias, IRYCIS, Madrid, Spain. angeles.juarranz@uam.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH